NTE In Action
Françoise Baylis is featured in an article in Dalhousie News (1 June 2018).
Françoise Baylis delivers a talk at the Big Thinking lecture series, Riddell Centre - RC 170 University Theatre, Congress 2018 of the Humanities and Social Sciences, Regina SK (31 May 2018, 12:15-13:15 Central Standard Time).
Françoise Baylis and other experts issue a fact sheet outlining critical concerns with the introduction of a private members’ bill to remove the criminal prohibition on payment for surrogacy, eggs, and sperm (29 May 2018).
Françoise Baylis and Jocelyn Downie participate in a panel discussion organized and moderated by Letitia Meynell, Paul O'Regan Hall, Halifax Central Library, Halifax NS (16 May 2018).
Lessons from Genetic Counselling and a Public Education Initiative on Cannabis Use, Genetics, and Mental Illness
Tim Krahn (co-authors Jehannine Austin & Rudolf Uher) gives an oral presentation at the Canadian Bioethics Society 2018 annual conference, Halifax, NS (25 May 2018, 2:00PM-2:30PM).
Justice Concerns and Investigating Questions of Funding Bias in Down Syndrome Research at the Canadian Institutes of Health Research
Tim Krahn (co-authors Chris Kaposy & Matthew Herder) gives a poster presentation at the Canadian Bioethics Society 2018 annual meeting, Halifax, NS.
NTE In Print
Françoise Baylis, Alana Cattapan and other experts from across Canada publish a fact sheet on the proposed changes to the AHR Act (29 May 2018).
Chris Kaposy publishes an Op-Ed in the New York Times (16 Apr 2018).
Françoise Baylis and Alice Dreger edit a set of book chapters on first-person case studies of attempts to fix serious ethical problems in medical practice and research.
Françoise Baylis & Marcus MacLeod provide comments on the Tri‐Council Policy Statement: Proposed Revisions to TCPS 2 (2014) Research Involving Human Cells and Cell Lines.
Françoise Baylis & Marcus McLeod publish a scholarly journal critically questioning whether we are ready for first-in-human Phase 1 CRISPR gene editing cancer trials [Open Access].
Françoise Baylis and Lisa Ikemoto comment on CRISPR/Cas9, eugenics concerns, and whether the Council of Europe's ban on human germline genome editing should continue.